(Total Views: 225)
Posted On: 04/01/2019 8:05:07 AM
Post# of 156966
What do you think of this senstence from the PR? Does this mean they started enrollment and will inject the first patient soon?
“CytoDyn has now opened a clinical trial (NCT03838367) that is assessing the efficacy of leronlimab (PRO 140) in metastatic triple negative breast cancer and will measure CTCs in the enrolled patients.”
“CytoDyn has now opened a clinical trial (NCT03838367) that is assessing the efficacy of leronlimab (PRO 140) in metastatic triple negative breast cancer and will measure CTCs in the enrolled patients.”
(0)
(0)
